Search

Search Results

• THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS

  FASOLA ATINUKE

  e2022001

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.001

  2720

  PDF: 992

  HTML: 77

• LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML

  Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles

  e2020020

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.020

  1787

  PDF: 1181

  HTML: 253

• THE BROAD-RANGING PANORAMA OF SYSTEMIC AUTOINFLAMMATORY DISORDERS WITH SPECIFIC FOCUS ON ACUTE PAINFUL SYMPTOMS AND HEMATOLOGIC MANIFESTATIONS IN CHILDREN

  Donato Rigante

  e2018067

  2018-10-30

  https://doi.org/10.4084/mjhid.2018.067

  2116

  PDF: 1295

  HTML: 384

• RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES

  Julie Schanz, Friederike Braulke, Detlef Haase

  e2015034

  2015-04-23

  https://doi.org/10.4084/mjhid.2015.034

  3817

  PDF: 1682

  HTML: 11630

  Figures Haase: 207

• miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS

  Meiwan Cao, BaoLing Peng, WanFu Xu, PeiYu Chen, Huan Chen, LiPing Ye, Jing Xie, HongLi Wang, Lu Ren, LiYa Xiong, JingNan Zhu, XiangYe Xu, LanLan Geng, SiTang Gong

  e2023040

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.040

  752

  PDF: 877

  PDF Supp. Files: 78

  HTML: 193

• Late-onset anicteric veno-occlusive disease after haploidentical HSCT: diagnostic challenges in the setting of CMV reactivation

  Thi Tuyet Mai Nguyen, Tuan Tung Nguyen, Van Tuan Ta

  e2026057

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.057

  146

  PDF: 91

  HTML: 19

• TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin

  Cristina Papayannidis, Vincenzo Federico, Luana Fianchi, Patrizia Pregno, Novella Pugliese, Alessandra Romano, Federica Irene Grifoni

  e2022073

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.073

  1266

  PDF: 1016

  HTML: 225

• GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey

  Mehmet Hilmi DOGU, Ali Irfan Emre TEKGUNDUZ, Burak DEVECI, Gulten KORKMAZ, Melda COMERT, Omur Gokmen SEVINDIK, Osman YOKUS, Istemi SERIN

  e2023031

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.031

  1464

  PDF: 915

  Suppl. Files: 457

  HTML: 245

• T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections

  Muhamad R. Abdel Hameed, Sherein G. Elgendy, Mohamed A El-Mokhtar, Douaa Sayed, Samar M. Mansour, Abeer M. Darwish

  e2022022

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.022

  1809

  PDF: 713

  HTML: 402

• INSULIN-LIKE GROWTH FACTOR-1 (IGF-1): DEMOGRAPHIC, CLINICAL AND LABORATORY DATA IN 120 CONSECUTIVE ADULT PATIENTS WITH THALASSAEMIA MAJOR

  V. De Sanctis

  e2014.074

  2014-11-01

  https://doi.org/10.4084/mjhid.2014.074

  2274

  PDF: 954

  HTML: 26949

• ACUTE PROMYELOCYTIC LEUKEMIA: AN EXPERIENCE ON 95 GREEK PATIENTS TREATED IN THE ALL-TRANS-RETINOIC ACID ERA

  Maria Pagoni, Maria Garofalaki, Fotios Panitsas, Kalliopi Manola, Katerina Psarra, Panagiotis Economopoulos

  e2011053

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.053

  2867

  PDF: 897

  HTML: 3586

• POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE

  Daniela Capello, Gianluca Gaidano

  e2009018

  https://doi.org/10.4084/mjhid.2009.018

  1314

  PDF: 477

  HTML: 18614

  Figure 1: 174

  Figure 2: 154

  Figure 3: 171

  Figure 4: 210

  Figure 5: 182

• The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

  Michele Bibas

  e2024015

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.015

  1807

  PDF: 1689

  HTML: 893

• HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

  Giuseppe Avvisati

  e2011064

  2011-12-19

  https://doi.org/10.4084/mjhid.2011.064

  13291

  PDF: 987

  HTML: 7296

• Molecular Expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinase plasma cellular disorders: a molecular panel to investigate disease progression

  Maria Cristina Rapanotti

  e2018059

  2018-10-30

  https://doi.org/10.4084/mjhid.2018.059

  1347

  PDF: 771

  HTML: 152

• CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.

  Luca Laurenti, Barbara Vannata, Idanna Innocenti, Francesco Autore, Francesco Santini, Nicola Piccirillo, Tommaso Za, Silvia Bellesi, Sara Marietti, Simona Sica, Dimitar G. Efremov, Giuseppe Leone

  e2013031

  2013-05-01

  https://doi.org/10.4084/mjhid.2013.031

  3255

  PDF: 913

  HTML: 1544

  Fig.1 CHL-R paper: 226

  Fig 2 CHL-R paper: 247

• Pathologic splenic rupture in a patient with follicular lymphoma

  Aniruddha P Dayama, Rajan Kapoor, Jasmita Dass, Gurmeet Singh, Manoranjan Mahapatra, Haraprasad Pati

  e2011051

  2011-11-10

  https://doi.org/10.4084/mjhid.2011.051

  1444

  PDF: 560

  HTML: 1195

  rupture: 186

• FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia

  Vincenzo De Sanctis, Forough Saki, Mehran Karimi, Mohammad Faranoush, Ihab Elhakim, Ashraf T Soliman, Shahina Daar, Ploutarchos Tzoulis

  e2025072

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.072

  672

  PDF: 254

  Html: 33

• ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

  Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante

  e2022008

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.008

  2298

  PDF: 1167

  HTML: 650

• GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

  Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau

  e2011019

  2011-05-16

  https://doi.org/10.4084/mjhid.2011.019

  2603

  PDF: 813

  HTML: 5231

• THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA  in TDT

  Vincenzo De Sanctis, Shahina Daar, Ploutarchos Tzoulis, Ashraf Soliman, Ihab Elhakim , Mohammad Faranoush, Christos Kattamis

  e2026055

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.056

  91

  PDF: 73

  HTML: 13

• NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION

  Augustine Avilès

  e2015052

  2015-08-30

  https://doi.org/10.4084/mjhid.2015.052

  1787

  PDF: 1002

  HTML: 1792

  Tables: 182

• CLASSIC KSHV/HHV-8-POSITIVE PRIMARY EFFUSION LYMPHOMA (PEL): A SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE REPORTS

  Ilaria Cozzi, Giovanni Rossi, Emma Rullo, Valeria Ascoli

  e2022020

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.020

  1577

  PDF: 968

  HTML: 330

• Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India

  Mary Theresa Sylvia, Biswajit Dey, Debdatta Basu, Sajini Elizabeth Jacob, Rakhee Kar, Biswajit Dubashi

  e2016060

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.060

  3225

  PDF: 787

  HTML: 2972

  Figure 1a and 1b: 154

  Figure 2: 164

  Figure 3: 182

  Figure 4: 165

  Figure 5: 168

  Tables 1-5: 156

• PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

  Rabab Aly, Mohamed R. El-sharnoby, Adel A. Hagag

  e2011055

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.055

  1899

  PDF: 764

  HTML: 1532

• THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA

  Yingying Li, Yang Li, Wenguo Cheng

  e2025073

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.073

  502

  PDF: 254

  HTML: 79

• Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

  Francesca Maria Quaglia, Gian Matteo Rigolin, Elena Saccenti, Massimo Negrini, Eleonora Volta, Melissa Dabusti, Maria Ciccone, Antonio Urso, Michele Laudisi, Antonio Cuneo

  e2019057

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.057

  1584

  PDF: 971

  HTML: 261

• Late-onset hepatic veno-occlusive disease after allografting: report of two cases with atypical clinical features successfully treated with defibrotide.

  Alessia Castellino, Stefano Guidi, Chiara Dellacasa, Antonella Gozzini, Irene Donnini, Chiara Nozzoli, Sara Manetta, Semra Aydin, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Enrico Maffini, Benedetto Bruno, Ezio David, Alessandro Busca

  e2018001

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.001

  4178

  PDF: 1128

  HTML: 998

• CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

  Juliana Maria Camargos Rocha, Sandra Guerra Xavier, Marcelo Eduardo Lima Souza, Juliana Godoy Assumpção, Mitiko Murao, Benigna Maria Oliveira

  e2016024

  2016-04-10

  https://doi.org/10.4084/mjhid.2016.024

  4617

  PDF: 1358

  HTML: 4629

• EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN

  Massimiliano Salati, Marina Cesaretti, Matteo Macchia, Mufid El Mistiri, Massimo Federico

  e2014048

  2014-06-29

  https://doi.org/10.4084/mjhid.2014.048

  3585

  PDF: 1205

  HTML: 5005

  Incidence age-standardized rates for HL across the Mediterranean basin: 210

• HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION

  Francesco Lo-Coco, Laura Cicconi

  e2011067

  2011-12-21

  https://doi.org/10.4084/mjhid.2011.067

  3198

  PDF: 1125

  HTML: 1781

• Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias

  Mehran Karimi, Sezaneh Haghpanah , Azita Azarkeivan , Sara Matin, Arash Safaei, Vincenzo De Sanctis

  e2021008

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.008

  1381

  PDF: 480

  HTML: 184

• CARBOXYHEMOGLOBIN LEVELS IN PRETERM NEONATAL LATE-ONSET SEPSIS: TO PREDICT OR NOT TO PREDICT

  GONCA VARDAR, Eren Ozek

  e2023017

  2023-02-28

  https://doi.org/10.4084/MJHID.2023.017

  1053

  PDF: 970

  HTML: 338

• PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW

  Kwame Ofori Adjepong, Folashade Otegbeye, Yaw Amoateng ADJEPONG

  e2018032

  2018-05-01

  https://doi.org/10.4084/mjhid.2018.032

  8530

  PDF: 3266

  HTML: 1255

• THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association

  Katia Paciaroni, Selenia Campagna, Nicoletta Villiva', Enrico Maffini, Francesca Celesti, Attilio Tordi, Mariangela Lombardi, Giulia Dragonetti, Tommaso Caravita di Toritto

  e2025023

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.023

  1087

  PDF: 1169

  HTML: 98

• COMPARATIVE STUDY ON THE MEASUREMENT OF LIVER T2* VALUES OF THALASSEMIA PATIENTS AND THE CLINICAL GRADING OF LIVER IRON CONCENTRATION BY DIFFERENT POST-PROCESSING SOFTWARE MEASUREMENT OF LIVER T2* VALUES OF THALASSEMIA

  Peng Peng, Fengming XU, Jixing YI, Bumin LIANG, Cheng TANG, Qing FENG

  e2022072

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.072

  873

  PDF: 615

  HTML: 212

• PATTERN OF CEREBRAL BLOOD FLOW VELOCITY USING TRANSCRANIAL DOPPLER ULTRASONOGRAPHY IN CHILDREN WITH SICKLE CELL DISORDER IN LAGOS STATE, NIGERIA

  Motunrayo Oluwabukola Adekunle

  e2017050

  2017-08-14

  https://doi.org/10.4084/mjhid.2017.050

  2073

  PDF: 859

  HTML: 826

• APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE

  Alberto L. García-Basteiro, Quique Bassat, Pedro L. Alonso

  e2012015

  2012-03-10

  https://doi.org/10.4084/mjhid.2012.015

  2597

  PDF: 980

  HTML: 15118

• Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

  Bhavya S Doshi, Valder R Arruda, Valder R Arruda

  e2020069

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.069

  2097

  PDF: 1908

  HTML: 352

• THE IMPACT OF PRE-ANALYTICAL FACTORS ON BLOOD GLUCOSE MEASUREMENTS AND  and recommendations THE IMPACT OF PRE-ANALYTICAL FACTORS ON BLOOD GLUCOSE MEASUREMENTS AND RECOMMENDATIONS  FOR CLINICAL PRACTICE: AN ICET-A MULTICENTER SURVEY IN TRANSFUSION-DEPENDENT Β THALASSEMIA (Β-TDT) PATIENTS

  Vincenzo De Sanctis, Christos Kattamis, Duran Canatan, Defne Ay Tuncel, Sule Unal , Dulani Kottahachchi, Mohamed A Yassin, Ashraf T Soliman, Saif Al Yaarubi , Yasser Wali, Mehran Karimi, Forough Saki, Mohammad Faranoush, Polyxeni Delaporta, Antonis Kattamis, Iskra Modeva, Ploutarchos Tzoulis, Shahina Daar, Irene Savvidou

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.035

  284

  PDF: 297

  HTML: 19

• PEDIATRIC TUBERCULOSIS IN THE NORTH SARDINIA

  Maria Grazia Clemente, Elena Dore, Lidia Abis, Paola Molicotti, Stefania Zanetti, Paolina Olmeo, Roberto Antonucci

  e2017027

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.027

  2495

  PDF: 877

  HTML: 2393

• Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia

  Monique A Hartley-Brown, Lubomir Sokol, Gisela L Caceres, Mohammed A Hussein, Alan List, Javier Pinilla-Ibarz

  e2010002

  2010-02-23

  https://doi.org/10.4084/mjhid.2010.002

  1048

  PDF: 554

  HTML: 404

• Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a real world setting

  Andrea Mattozzi, Eugenio Galli, Francesco Autore, Ilaria Pansini, Patrizia Chiusolo, Simona Sica, Federica Sorà

  e2026013

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.013

  602

  PDF: 512

  Html: 85

• TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.

  Charicleia Kelaidi, Lionel Ades, Pierre Fenaux

  e2011038

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.038

  2511

  PDF: 954

  HTML: 2372

• Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide

  Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu

  e2025038

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.038

  1048

  PDF: 751

  HTML: 90

• Bacillus cereus in the neutropenic patient: case report in a patient with myelodysplastic syndrome and review of the literature

  Mariam Markouli, Sevastianos Chatzidavid, Dimitra Vlachopoulou, Nefeli Giannakopoulou, Amalia Anastasopoulou, Nora-Athina Viniou, Panagiotis Diamantopoulos

  e2022071

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.071

  967

  PDF: 813

  HTML: 205

• OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY

  Mohamed Amine BEKADJA

  e2017062

  2017-10-25

  https://doi.org/10.4084/mjhid.2017.062

  2878

  PDF: 741

  HTML: 912

• FIRST-PHASE INSULIN RESPONSE (FPIR) TO INTRAVENOUS GLUCOSE TOLERANCE TEST (IVGTT), INSULIN SENSITIVITY AND LONG-TERM FOLLOW-UP IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT) NORMOGLYCEMIC PATIENTS WITH REDUCED INSULIN SECRETION TO ORAL GLUCOSE TOLERANCE TEST: A PILOT STUDY. The function of the endocrine pancreas in transfusion-dependent ?-thalassemia

  Vincenzo De Sanctis

  e2021021

  2021-02-26

  https://doi.org/10.4084/mjhid.2021.021

  7379

  PDF: 571

  HTML: 237

• A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.

  Roula Antoine Farah

  e2015012

  2014-12-27

  https://doi.org/10.4084/mjhid.2015.012

  2104

  PDF: 1131

  HTML: 7712

  cover letter paper final AML: 224

• Late-Onset Veno-Occlusive Disease (VOD) Post-Haploidentical Transplant: A Diagnostic Challenge Requiring Liver Biopsy– A Case Report

  Mehak Trehan, Homdutt Sharma, Abhinav Sengupta, Anirudh Burli, Pradeep Kumar, Manoranjan Mahapatra

  e2025068

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.068

  971

  PDF: 472

  Html: 146